Related Experiment Video
Updated: Sep 26, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease
Angharad R Morgan1, Baiping Zhang, William Tapper
1Human Genetics Division, School of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.
Insights
Genetic variations in the matrix metalloproteinase-9 (MMP-9) gene are linked to coronary artery disease risk. Specific MMP-9 gene polymorphisms influence atherosclerosis development and severity, impacting coronary stenosis risk.
Area of Science:
- Cardiovascular Genetics
- Molecular Medicine
Background:
- Atherosclerosis, the primary cause of coronary artery disease, involves matrix metalloproteinase-9 (MMP-9).
- Genetic variations in the MMP-9 gene may influence atherosclerosis development.
Purpose of the Study:
- To investigate the association between common MMP-9 gene polymorphisms and the development of atherosclerosis.
- To determine if MMP-9 genetic variations impact the risk and severity of coronary stenosis.
Main Methods:
- Analyzed three common MMP-9 polymorphisms (-1562C>T, R+279Q, +6C>T) in 1510 white subjects undergoing coronary angiography.
- Utilized logistic regression and haplotype analyses to assess the relationship between genotypes, alleles, haplotypes, and coronary stenosis.
Main Results:
- The -1562C>T polymorphism showed significantly higher frequencies in patients with coronary stenosis.
- Carrying the -1562T allele was associated with a 1.5-fold increased risk of coronary stenosis.
- The C-G-C haplotype demonstrated a protective effect, reducing the risk and severity of coronary atherosclerosis.
Conclusions:
- Genetic variation in the MMP-9 gene significantly influences the development and progression of atherosclerosis.
- The -1562C>T polymorphism and the C-G-C haplotype are key genetic factors affecting coronary artery disease risk.
- MMP-9 gene polymorphisms impact both the susceptibility and the extent of coronary stenosis.
Abstract:
Matrix metalloproteinase-9 (MMP-9) plays an important role in the pathogenesis of atherosclerosis, the pathology underlying the majority of coronary artery disease. We previously identified several polymorphisms in the gene encoding MMP-9. In this study we tested the hypothesis that variation in the matrix metalloproteinase-9 gene influences the development of atherosclerosis. Three common polymorphisms, i.e. -1562C>T, R+279Q and +6C>T, were analysed in 1510 white subjects undergoing coronary angiography. Analyses of individual polymorphisms showed that the frequencies of the C/T and T/T genotypes of the -1562C>T polymorphism were significantly higher in patients with coronary stenosis than in those with a normal angiogram. Logistic regression analyses indicated that individuals carrying the -1562T allele had an approx. 1.5-fold higher risk of developing coronary stenosis (OR 1.49, 95% CI 1.039-2.144), which was equivalent to an over 30% reduction in risk of coronary stenosis in individuals not carrying this allele (OR 0.670, 95% CI 0.467-0.963). The three polymorphisms studied were found to be in strong linkage disequilibrium. Haplotype analyses showed that the C-G-C haplotype (-1562C, +279Q and +6C) was associated with a protective effect against atherosclerosis. Individuals carrying this haplotype were at reduced risk of developing coronary stenosis (OR 0.695, 95% CI 0.530.92). Furthermore, the C-G-C haplotype was associated with less severe coronary atherosclerosis, i.e. carriers of this haplotype were at a lower risk of having coronary stenosis in more than one coronary artery (OR 0.796, 95% CI 0.640.99). These data, together with the previous finding that the -1562T allele has a higher transcriptional activity than the -1562C allele, support the notion that genetic variation with an effect on MMP-9 expression influences the development and progression of atherosclerosis.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
